Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Comment on "characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: an ANRS CO16 LYMPHOVIR cohort study".

Chang PY, Detels R, Martínez-Maza O, Zhang ZF, Jacobson LP, Margolick JB, Variakojis D, Rinaldo CR Jr, Hussain SK.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):e84-6. doi: 10.1097/QAI.0000000000000204. No abstract available.

2.

Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: an ANRS CO16 LYMPHOVIR cohort study.

Terrier B, Costagliola D, Prevot S, Chavez H, Missy P, Rince P, Costello R, Escaut L, Gabarre J, Joly B, Letranchant L, Le Gouill S, Morineau-Le Houssine P, Simon A, Canioni D, Hermine O, Cacoub P, Taoufik Y, Raphael M, Besson C.

J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):249-53. doi: 10.1097/QAI.0b013e31828a77f0.

PMID:
23403861
3.

Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients.

Terrier B, Costagliola D, Besson C.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):e86-7. doi: 10.1097/QAI.0000000000000272. No abstract available.

PMID:
24977475
4.

Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.

Simcock M, Blasko M, Karrer U, Bertisch B, Pless M, Blumer L, Vora S, Robinson JO, Bernasconi E, Terziroli B, Moirandat-Rytz S, Furrer H, Hirschel B, Vernazza P, Sendi P, Rickenbach M, Bucher HC, Battegay M, Koller MT; Swiss HIV Cohort Study.

Antivir Ther. 2007;12(6):931-9.

PMID:
17926647
5.

Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort study.

Waters L, Stebbing J, Mandalia S, Young AM, Nelson M, Gazzard B, Bower M.

Int J Cancer. 2005 Aug 10;116(1):161-3.

6.

High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.

Besson C, Lancar R, Prevot S, Brice P, Meyohas MC, Marchou B, Gabarre J, Bonnet F, Goujard C, Lambotte O, Boué F, Mounier N, Partisani M, Raffi F, Costello R, Hendel-Chavez H, Algarte-Genin M, Trabelsi S, Marchand L, Raphael M, Taoufik Y, Costagliola D.

Clin Infect Dis. 2015 Nov 1;61(9):1469-75. doi: 10.1093/cid/civ627. Epub 2015 Jul 29.

PMID:
26223997
7.

Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.

Challine D, Buisson M, Cadilhac M, Germanidis G, Joab I, Eliaszewicz M, Caumes E, Flahault A, Fillet AM, Pawlotsky JM, Seigneurin JM.

J Med Virol. 2002 Aug;67(4):510-5.

PMID:
12115996
8.
9.

Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus.

Lai AR, Tashima KT, Taylor LE.

AIDS Patient Care STDS. 2006 Oct;20(10):678-92. Review.

PMID:
17052138
10.
11.

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group.

Arch Intern Med. 2002 Oct 14;162(18):2125-32.

PMID:
12374521
12.

Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma.

Leruez-Ville M, Seng R, Morand P, Boufassa F, Boue F, Deveau C, Rouzioux C, Goujard C, Seigneurin JM, Meyer L.

HIV Med. 2012 Sep;13(8):479-87. doi: 10.1111/j.1468-1293.2012.00998.x. Epub 2012 Mar 14.

13.

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.

Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, Wood KC, Holmberg SD; HIV Outpatient Study (HOPS) Investigators.

Clin Infect Dis. 2003 Feb 1;36(3):363-7. Epub 2003 Jan 14.

PMID:
12539079
14.

Lack of association between HCV infection and HIV-related lymphoma.

Besson C, Pialoux G, Dupont B, Pol S, Hermine O, Arnulf B, Landau A, McCormick JB.

Br J Haematol. 1999 May;105(2):568-9. No abstract available.

PMID:
10233441
15.

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD; HepaI.Co.N.A. Study Group; Italian Cohort Naive for Antiretrovirals Study Group.

Clin Infect Dis. 2005 Jun 15;40(12):e101-9. Epub 2005 May 5.

PMID:
15909251
16.

Optimizing antiretroviral therapy for HCV coinfected people.

Swan T.

GMHC Treat Issues. 2006 Apr-Jul;20(4-7):9-11. No abstract available.

PMID:
17228450
17.

HIV and hepatitis C coinfection.

Matthews GV, Dore GJ.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1000-8. doi: 10.1111/j.1440-1746.2008.05489.x. Review.

PMID:
18707597
18.

Brief Report: Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1-HCV-Coinfected Patients Who Either Received Interferon-α/Ribavirin-Based Hepatitis C Therapy or Had Spontaneous HCV RNA Clearance.

Abad-Fernández M, Dronda F, Moreno A, Casado JL, Pérez-Elías MJ, Quereda C, Moreno S, Vallejo A.

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):286-90. doi: 10.1097/QAI.0000000000000608.

PMID:
26181704
19.

Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.

Smit C, van den Berg C, Geskus R, Berkhout B, Coutinho R, Prins M.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):221-5. doi: 10.1097/QAI.0b013e31815d2f59.

PMID:
18223361
20.

[Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV].

Gavazzi G, Richallet G, Morand P, Bouchard O, Bosseray A, Leclercq P, Micoud M.

Pathol Biol (Paris). 1998 Jun;46(6):412-5. French.

PMID:
9769871

Supplemental Content

Support Center